Robeco Institutional Asset Management B.V. Vir Biotechnology, Inc. Transaction History

Robeco Institutional Asset Management B.V.

  • $51.9 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023
SELL
$9.14 - $24.62 $378,167 - $1.02 Million
-41,375 Reduced 30.62%
93,752 $878,000
Q1 2023

May 03, 2023
BUY
$22.26 - $30.85 $1.1 Million - $1.53 Million
49,470 Added 57.75%
135,127 $3.14 Million
Q4 2022

Feb 06, 2023
BUY
$19.96 - $28.22 $1.05 Million - $1.49 Million
52,746 Added 160.27%
85,657 $2.17 Million
Q3 2022

Oct 26, 2022
BUY
$18.26 - $31.1 $600,954 - $1.02 Million
32,911 New
32,911 $635,000

Others Institutions Holding VIR

# of Institutions
228
Shares Held
88.4M
Call Options Held
571K
Put Options Held
216K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.28B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email